The study only involved people with type 2 diabetes, so its still unclear whether the same pattern holds for the much larger group now taking these drugs purely for weight loss
Lancet Diabetes Endocrinol 6(8):605617 Tuttle KR, Lakshmanan MC, Rayner B, Busch RS, Zimmermann AG, Woodward DB et al (2018b) Dulaglutide versus insulin glargine in patients with type 2 diabetes and moderate-to-severe chronic kidney disease (AWARD-7): a multicentre, open-label, randomised trial
Customer Reviews: What Real Users Say What people praise: Customer service responsiveness many users report prompt responses to questions within the portal and via phone support Forever rate locked in for your commitment length the fact that a monthly rate that doesnt change is unique in this space is heavily praised by customers Quick product turnaround many users praise how quickly they recieve the medication B12 included some users praise how B12 is included in subscriptions Doctors will adjust based on history a user reported speaking to a provider who agreed to keep him on his prior dose What people complain about: Make sure to select the correct plan
It indirectly prolongs fasting periods, reduces meal frequency, and decreases meal-initiation pleasure via dopamine pathways
What Is altRx
Press release, 2024
